FMO3 and systemic sclerosis: Additionally, the skin of SSc patients was characterized by 1.69- to 4.29-fold-higher FMO3 expression compared to control skin [137,138,139], which suggests that cell autonomous upregulation of FMO3 in SSc fibroblasts might contribute to their elevated collagen production underlying fibrosis.